Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

Nature Genetics

Volumn 9, Issue 4, 1995, Pages 444-450

  Thompson, Marilyn E ^a   Jensen, Roy A ^a   Obermiller, Patrice S ^a   Page, David L ^a   Holt, Jeffrey T ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REPRESSION; GENETIC SUSCEPTIBILITY; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ALLELES; BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA IN SITU; CELL DIVISION; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0028950999     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0495-444     Document Type: Article

References (24)

1. Hall, J.M. et al. Linkage of early-onset breast cancer to chromosome 17q21. Science 250, 1684-1689 (1990).
2. Miki, Y. et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71 (1994).
3. Friedman, L.S. et al.Confirmation of BRCA by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nature Genet. 8, 399-404 (1994).
4. Castilla, L.C. et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet. 8, 387-391 (1994).
5. Simard, J. et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet. 8, 392-398 (1994).
6. Narod, S.A. et al. A heterogeneity analysis of 145 breast-ovarian cancer families. Am. J. hum. Genet. 56, 254-264 (1995).
7. Merajver, S. et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet. 9, 439-443 (1995).
8. Holt, J.T., Jensen, R.A. & Page, D.L., Old principles and new methods. inCancer Surveys Advances and Prospects in Clinical, Epidemiological and Laboratory Oncology (eds Fentiman, I. & Taylor-Papadimitriou, J.) 18, 115-133 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1993).
9. Jensen, R.A., Page, D.L. & Holt. J.T. Identification of genes expressed in premalignant breast disease by microscopy-directed cloning. Proc. natn.Acad. Sci. U.S.A. 91, 9257-9261 (1994).
10. Betsill, W.L., Rosen, P.P., Liberman, P.M. & Robbins, G.F. Intraductal carcinoma: long-term follow-up after treatment by biopsy alone. J. Am. med. Assoc. 239, 1863-1867 (1978).
11. Page, D.L., Dupont, W.D., Rogers, L.W. & Landenberger, M. Intraductal carcinoma of the breast: follow-up after biopsy. Cancer 49, 751-758 (1982).
12. Page, D.L. & Dupont, W.D. Atypical hyperplastic lesions of the female breast. A long term follow-up study. Cancer 66, 1326-1335 (1990).
13. Stampfer, M., Hallowes, R.C. & Hackett, A.J. Growth of normal human mammary cells in culture. In Vitro 16, 415-425 (1980).
14. Soule, H.D. & McGrath, C.M. Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Letters 10, 177-189 (1980).
15. Robinson-Benion, C. & Holt, J.T. Antisense strategies for oncogene research in Methods in Enzymology (eds Vogt, P. & Verma, I.) (Academic Press, San Diego, in the press).
16. Marcus, J.N., Watson, P., Page, D.L. & Lynch, H.T. Pathology and heredity of breast cancer in younger women. J. natn.Cancer. Inst. Monograph No. 16, 23-34 (1994).
17. Neuhausen, S.L. & Marshall, C.J. Loss of heterozygosity in familial tumours from three BBCAJ-linked kindreds. Cancer Res. 54, 6069-6072 (1994).
18. Jacobs, I.J. et al. A deletion unit on chromosome 17q in epithelial ovarian tumours distal to the familial breast/ovarian cancer locus. Cancer Res. 53, 1218-1221 (1993).
19. Saito, H. et al. 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumours. Cancer Res. 53, 3382-3385 (1993).
20. Cropp, C.S. et al. Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res. 54, 2548-2551 (1994).
21. Xue, D., Tu, Y. & Chalfle, M. Cooperative interactions between the C. elegans homoproteins Unc-86 and Mec-3. Science 261, 1324-1328 (1993).
22. Reuter, R. et al. Homeotic genes regulate the spacial expression of putative growth factors in the visceral mesoderm of Drosophlla embryos.Development 110, 1031-1040 (1990).
23. Page, D.L. & Dupont, W.D. Anatomic indicators (histologic and cytologic) of increased breast cancer risk. Breast Cancer Res. Treat. 28, 157-166 (1993).
24. Holt, J.T., Redner, R.L. & Nienhuis, A.W. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytlc cells and induces differentiation. Molec. cell. Biol. 8, 963-973 (1988).